| 1 |
Grundtman C, Wick G. The autoimmune concept of atherosclerosis. Curr Opin Lipidol 2011;22:327-34.
DOI
ScienceOn
|
| 2 |
Siess W. Platelet interaction with bioactive lipids formed by mild oxidation of low-density lipoprotein. Pathophysiol Haemost Thromb 2006; 35:292-304.
DOI
ScienceOn
|
| 3 |
Siegel-Axel D, Daub K, Seizer P, Lindemann S, Gawaz M. Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis. Cardiovasc Res 2008;78:8-17.
DOI
ScienceOn
|
| 4 |
Zimman A, Podrez EA. Regulation of platelet function by class B scavenger receptors in hyperlipidemia. Arterioscler Thromb Vasc Biol 2010; 30:2350-6.
DOI
ScienceOn
|
| 5 |
Akkerman JW. From low-density lipoprotein to platelet activation. Int J Biochem Cell Biol 2008;40:2374-8.
DOI
ScienceOn
|
| 6 |
Hackeng CM, Huigsloot M, Pladet MW, Nieuwenhuis HK, van Rijn HJ, Akkerman JW. Low-density lipoprotein enhances platelet secretion via integrin-alphaIIbbeta3-mediated signaling. Arterioscler Thromb Vasc Biol 1999;19:239-47.
DOI
ScienceOn
|
| 7 |
Kang DY, Park KW, Lee SR, et al. Lack of association between low density lipoprotein particle size and on-treatment platelet reactivity in patients with coronary artery disease. Korean Circ J 2012;42:551-7.
DOI
|
| 8 |
Pontrelli L, Parris W, Adeli K, Cheung RC. Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes. Metabolism 2002;51:334-42.
DOI
ScienceOn
|
| 9 |
Maschberger P, Bauer M, Baumann-Siemons J, et al. Mildly oxidized low density lipoprotein rapidly stimulates via activation of the lysophosphatidic acid receptor Src family and Syk tyrosine kinases and Ca2+ influx in human platelets. J Biol Chem 2000;275:19159-66.
DOI
|
webmaster
